San Francisco, California, 15 June 2021 – Metabiota, the San Francisco-based company that specializes in infectious disease risk analytics, was selected among hundreds of candidates as one of the World Economic Forum’s “Technology Pioneers”. Founded in 2008, Metabiota has over a decade of experience partnering with businesses and governments worldwide to build resilience to epidemics and protect global public health.

The World Economic Forum’s Technology Pioneers are early to growth-stage companies from around the world that are involved in the use of new technologies and innovation that are poised to have a significant impact on business and society.

With their selection as Technology Pioneer, CEO Nita Madhav of Metabiota will be invited to participate at World Economic Forum activities, events, and discussions throughout the year. Metabiota will also contribute to Forum initiatives over the next two years, working with global leaders to help address key industry and societal issues.

“We’re excited to welcome Metabiota to our 2021 cohort of Technology Pioneers,” says Susan Nesbitt, Head of the Global Innovators Community, World Economic Forum. “Metabiota and its fellow pioneers are developing technologies that can help society solve some of its most pressing issues. We look forward to their contribution to the World Economic Forum in its commitment to improving the state of the world.”

“It’s a great honor to be acknowledged as a pioneer by the World Economic Forum”, said Metabiota’s Nita Madhav. “This provides validation that our technology is among the most unique in the world to build health systems, societies, and economies that are more resilient to infectious diseases. Our technology can help risk mitigation efforts as infectious diseases continue to pose an increasing global threat. We look forward to contributing to the Forum dialogues on this challenge.”